Sio Capital Management, LLC Sutro Biopharma, Inc. Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$7.44 - $13.15 $1.1 Million - $1.95 Million	-148,400 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $1.07 Million - $1.64 Million	148,400 New	148,400 $1.15 Million
Q3 2019 Nov 14, 2019	SELL	$7.91 - $11.76 $2.68 Million - $3.99 Million	-339,059 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$9.69 - $12.23 $578,851 - $730,583	-59,737 Reduced 14.98%	339,059 $3.86 Million
Q1 2019 May 15, 2019	BUY	$8.8 - $11.87 $1.03 Million - $1.39 Million	116,882 Added 41.46%	398,796 $4.54 Million
Q4 2018 Feb 14, 2019	BUY	$8.69 - $14.85 $429,068 - $733,218	49,375 Added 21.23%	281,914 $2.54 Million
Q3 2018 Nov 14, 2018	BUY	$15.0 - $15.2 $3.49 Million - $3.53 Million	232,539 New	232,539 $3.49 Million

128

59.9M

203K

33.6K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $92.3M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.